RESULTS OF OPEN SURGERY FOR ADVANCED GASTRIC CARCINOMA AT HA NOI MEDICAL UNIVERSITY HOSPITAL
Main Article Content
Abstract
Objectives: Describe clinical and paraclinical characteristics and outcome assessment for late-stage gastric cancer by open surgery for gastric carcinoma at the Department of General Surgery - Hanoi Medical University Hospital. Methods: Retrospective descriptive study analyzed 35 patients who were definitively diagnosed with gastric cancer and underwent open gastrectomy at the Department of General Surgery - Hanoi Medical University Hospital from January 2022 to December 2023. Results and discussion: The mean age of the study group was 64.71 ± 13.39, the lowest: 39 years old, the highest: 91 years old. The most common age group was over 60 years old, accounting for 68.57%. Males were more frequently than women, with a male/female ratio of 1.92/1. Epigastric pain was the most common symptom observed in 85.71% of cases. The mean operative time was 153.94 ± 60.63 minutes. Distal gastrectomy was the most frequently performed procedure, accounting for 68.57% of cases, whereas extended gastrectomy was required in 8.57% of patients. The majority of cases underwent gastrointestinal reconstruction was predominantly achieved using the Finsterer method. The mean number of lymph nodes dissected during surgery was 33.35 ± 14.32 (9-69 nodes). The mean number of metastatic lymph nodes was 10.16 ± 9.33, including a mean of 6.48 ± 5.63 metastatic nodes in the first station and 3.88 ± 4.72 metastatic nodes in the second station. The estimated overall survival (OS) was 29.89 ± 1.41 months, CI95% [21.13–32.65], and the disease-free survival (DFS) was 8.88 ± 2.08 months, CI95% [4.81-12.95]. Conclusions: Gastric cancer symptoms are not specific, and the rate of patients diagnosed at a late stage is still high. Open gastrectomy and lymph node dissection are often used in advanded gastric cancer or cases with complications that cannot be treated by laparoscopic surgery. This is a safe surgery with a very low rate of postoperative complications and prolongation of survival times
Article Details
Keywords
Advanced gastric cancer, radical surgery, long-term results
References


2. Sekiguchi M, Oda I, Matsuda T, Saito Y. Epidemiological Trends and Future Perspectives of Gastric Cancer in Eastern Asia. Digestion. 2022;103(1):22-28. doi:10.1159/000518483


3. Ang TL, Fock KM. Clinical epidemiology of gastric cancer. Singapore Med J. 2014; 55(12):621-628. doi:10.11622/smedj.2014174


4. Gennari L, Bozzetti F, Bonfanti G, et al. Subtotal versus total gastrectomy for cancer of the lower two-thirds of the stomach: a new approach to an old problem. Br J Surg. 1986;73(7):534-538. doi:10.1002/bjs.1800730706


5. Cianchi F, Indennitate G, Trallori G, et al. Robotic vs laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer: a retrospective comparative mono-institutional study. BMC Surg. 2016;16(1):65. doi:10.1186/ s12893-016-0180-z


6. Catarci, M., et al., Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution. Updates Surg, 2010. 62(2): p. 89-99.

7. Fujitani K, Kwang Yang H et al (2016), “Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer witha single non-curable factor (REGATTA): a phase 3, randomized controlled trial”, The Lancet Oncology, s1470-2045 (15), pp. 1-10.

8. Zhong Zhang J, Shan Lu H et al (2011), “Outcome of palliative total gastrectomy forstage IV proximal gastric cancer”, Am J Surg, 202(1), pp.

9. Park JH, Jeong SH, Lee YJ, et al. Comparison of long-term oncologic outcomes of laparoscopic gastrectomy and open gastrectomy for advanced gastric cancer: A retrospective cohort study. Korean J Clin Oncol. 2018;14:21-29.

10. Zhao LY, Zhang WH, Chen XZ, et al. Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study. Medicine (Baltimore). 2015;94(50): e2288.
